Clinical Trial Update: Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization [NA]

View source ↗

Summary

This trial update reports on the completed study of topical bevacizumab (Avastin) for corneal neovascularization, detailing its effectiveness and safety with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Corneal Neovascularization | NA | Status: COMPLETED | Results posted: 2013-07-03